Jang Lee - MEDIPOST Vice President Director
| 078160 Stock | KRW 12,350 380.00 3.17% |
President
Lee Jang Yeong is Managing Director of MediPost Co., Ltd. Lee used to be Assistant Managing Director of PACIFIC PHARMACEUTICAL CO., LTD. Lee holds a Bachelor degree in Food Engineering and a Master degree in MarketingCorporationrate Finance from Yonsei University, a Master degree and a Doctorate degree in Biological Sciences from Korea Advanced Institute of Science Technology.
| Age | 44 |
| Phone | (82) 2 3465 6688 |
| Web | www.medi-post.co.kr |
MEDIPOST Management Efficiency
The company has return on total asset (ROA) of (0.0113) % which means that it has lost $0.0113 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 1.8711 %, meaning that it generated $1.8711 on every $100 dollars invested by stockholders. MEDIPOST's management efficiency ratios could be used to measure how well MEDIPOST manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | 1.87 | |||
| Return On Asset | -0.0113 |
MEDIPOST Leadership Team
Elected by the shareholders, the MEDIPOST's board of directors comprises two types of representatives: MEDIPOST inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MEDIPOST. The board's role is to monitor MEDIPOST's management team and ensure that shareholders' interests are well served. MEDIPOST's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MEDIPOST's outside directors are responsible for providing unbiased perspectives on the board's policies.
| JangWon Lee, Sr Director | ||
| Won Oh, Vice President Director | ||
| Jin Kim, Director | ||
| Yun Yang, Chief Executive Officer, Director | ||
| Hyeon Min, Non-Executive Independent Director | ||
| YoungHwan Song, Head Director | ||
| YoonSeon Yang, CEO Pres | ||
| HyeKyung Hong, Director Director | ||
| WonII MD, VP Laboratory | ||
| Dong Hwang, President Director | ||
| SungHo Han, Head Director | ||
| Hong Kim, Director | ||
| SooJin MD, Director Director | ||
| Jang Lee, Vice President Director |
MEDIPOST Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MEDIPOST a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 1.87 | |||
| Return On Asset | -0.0113 | |||
| Profit Margin | (0.10) % | |||
| Operating Margin | (0.07) % | |||
| Current Valuation | 453 B | |||
| Shares Outstanding | 15.38 M | |||
| Shares Owned By Insiders | 6.96 % | |||
| Shares Owned By Institutions | 6.54 % | |||
| Price To Earning | 9,636 X | |||
| Price To Sales | 4.23 X |
Pair Trading with MEDIPOST
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MEDIPOST position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEDIPOST will appreciate offsetting losses from the drop in the long position's value.Moving against MEDIPOST Stock
| 0.76 | 055550 | Shinhan Financial | PairCorr |
| 0.68 | 005935 | Samsung Electronics | PairCorr |
| 0.64 | 005930 | Samsung Electronics | PairCorr |
| 0.62 | 005380 | Hyundai Motor | PairCorr |
The ability to find closely correlated positions to MEDIPOST could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MEDIPOST when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MEDIPOST - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MEDIPOST Co to buy it.
The correlation of MEDIPOST is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MEDIPOST moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MEDIPOST moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MEDIPOST can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in MEDIPOST Stock
MEDIPOST financial ratios help investors to determine whether MEDIPOST Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MEDIPOST with respect to the benefits of owning MEDIPOST security.